Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Cash from Investing Activities (2024 - 2025)

Beta Bionics' Cash from Investing Activities history spans 2 years, with the latest figure at $658000.0 for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 102.22% year-over-year to $658000.0; the TTM value through Dec 2025 reached -$162.8 million, down 4583.69%, while the annual FY2025 figure was -$162.8 million, 4583.69% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was $658000.0 at Beta Bionics, down from $9.5 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $15.2 million in Q3 2024 and bottomed at -$179.1 million in Q1 2025.